Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cryo-Cell International Inc. (CCEL : NSDQ)
 
 • Company Description   
CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.

Number of Employees: 93

 
 • Price / Volume Information   
Yesterday's Closing Price: $6.08 Daily Weekly Monthly
20 Day Moving Average: 3,235 shares
Shares Outstanding: 8.46 (millions)
Market Capitalization: $51.40 (millions)
Beta: 0.58
52 Week High: $14.16
52 Week Low: $6.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.89% 4.22%
12 Week -27.42% -19.98%
Year To Date -47.63% -37.26%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
700 Brooker Creek Boulevard Suite 1800
-
Oldsmar,FL 34677
USA
ph: 813-749-2100
fax: 813-855-4745
investors@cryo-cell.com http://www.cryo-cell.com
 
 • General Corporate Information   
Officers
David Portnoy - Chairman and Co-Chief Executive Officer
Jill Taymans - Chief Financial Officer
Mark Portnoy - Co-Chief Executive Officer
Harold Berger - Director
Daniel Mizrahi - Director

Peer Information
Cryo-Cell International Inc. (CHCR)
Cryo-Cell International Inc. (ESRX)
Cryo-Cell International Inc. (MYDP)
Cryo-Cell International Inc. (GBCS)
Cryo-Cell International Inc. (LAXAF)
Cryo-Cell International Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 228895108
SIC: 8090
Fiscal Year
Fiscal Year End: November
Last Reported Quarter: 02/01/22
Next Expected EPS Date: 07/21/22
Share - Related Items
Shares Outstanding: 8.46
Most Recent Split Date: (:1)
Beta: 0.58
Market Capitalization: $51.40 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/21/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 23.37
PEG Ratio: -
Price Ratios
Price/Book: 12.15
Price/Cash Flow: 14.95
Price / Sales: 1.76
EPS Growth
vs. Year Ago Period: 25.00%
vs. Previous Quarter: 225.00%
Sales Growth
vs. Year Ago Period: 5.80%
vs. Previous Quarter: -0.77%
ROE
02/28/22 - 51.59
11/30/21 - 73.86
08/31/21 - 350.92
ROA
02/28/22 - 3.81
11/30/21 - 2.94
08/31/21 - 5.79
Current Ratio
02/28/22 - 0.59
11/30/21 - 0.75
08/31/21 - 0.75
Quick Ratio
02/28/22 - 0.54
11/30/21 - 0.71
08/31/21 - 0.71
Operating Margin
02/28/22 - 7.59
11/30/21 - 7.22
08/31/21 - 13.41
Net Margin
02/28/22 - 7.59
11/30/21 - 7.22
08/31/21 - 13.41
Pre-Tax Margin
02/28/22 - 9.61
11/30/21 - 9.04
08/31/21 - 19.56
Book Value
02/28/22 - 0.50
11/30/21 - 0.49
08/31/21 - 0.57
Inventory Turnover
02/28/22 - 10.17
11/30/21 - 10.24
08/31/21 - 10.24
Debt-to-Equity
02/28/22 - 0.00
11/30/21 - 0.00
08/31/21 - 0.00
Debt-to-Capital
02/28/22 - 0.00
11/30/21 - 0.00
08/31/21 - 0.00
 

Powered by Zacks Investment Research ©